BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Deals

  Vimian Group Acquires Supplier of Veterinary Surgical Products in New Zealand and Australia

  Vimian Group has signed an agreement to acquire Kahu Vet Group, a supplier of veterinary surgical products in New Zealand and Australia.

  February 3, 2022

   · 

  3 min read
• BioMidwest

  Axogen to Participate at Upcoming Investor Conferences - Feb 03, 2022

  Karen Zaderej, chairman, CEO, and president will participate in a fireside discussion at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 15, 2022 at 1:25 p.m. ET.

  February 3, 2022

   · 

  2 min read
• Biotech Bay

  CareDx To Participate In Upcoming Conferences - Feb 03, 2022

  CareDx, Inc. announced that the Company will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference and the Raymond James 43rd Annual Institutional Investors Conference.

  February 3, 2022

   · 

  1 min read
• Policy

  Pardes Biosciences Announces FDA Clearance of IND Application for PBI-0451, an Oral Antiviral Drug Candidate for the Treatment and Prevention of SARS-CoV-2 Infections

  Pardes Biosciences, Inc. announced that its Investigational New Drug application for PBI-0451 has been cleared by the United States Food and Drug Administration.

  February 3, 2022

   · 

  4 min read
• Business

  Anavex Life Sciences to Announce Fiscal 2022 First Quarter Financial Results on Wednesday, February 9, 2022

  Anavex Life Sciences Corp. announced that it will issue financial results for its fiscal quarter ended December 31, 2021 on Wednesday, February 9, 2022.

  February 3, 2022

   · 

  3 min read
• Business

  Freeline Appoints Henning R. Stennicke, PhD, as Chief Scientific Officer to Lead Research and Discovery

  Freeline Therapeutics Holdings plc announced the expansion of its executive leadership team with the appointment of Henning R. Stennicke, PhD, as Chief Scientific Officer.

  February 3, 2022

   · 

  8 min read
• Intrivo Launches The On/Go™ Advanced Care Toolkit (ACT) To Support Those Who Test Positive For COVID-19

  Intrivo, a U.S.-based health-tech leader, launched the beta version of its On/Go Advanced Care Toolkit (ACT), a one-of-a-kind rapid-testing support solution available for free in the On/Go mobile app exclusively for people who use the company’s On/Go COVID-19 Antigen Self-Test.

  February 3, 2022

   · 

  4 min read
• Business

  Engage Technologies Group Selects David Pennington, RN, BSN, MBA as SVP, Engage Ocular

  Engage Technologies Group, Inc. has announced David Pennington, RN , BSN, MBA as its new Senior Vice President of Engage Ocular.

  February 3, 2022

   · 

  3 min read
• BioCapital

  Graybug to Participate in Three Upcoming Medical and Investor Conferences

  Graybug Vision, Inc. announced its participation in three upcoming medical and investor conferences:

  February 3, 2022

   · 

  4 min read
• Business

  Salarius Pharmaceuticals Appoints Daniela Santiesteban, Ph.D., to Director of Targeted Protein Degradation Program

  Salarius Pharmaceuticals, Inc. today announced that Daniela Santiesteban, Ph.D., has been named Director of the Company’s new targeted protein degradation program.

  February 3, 2022

   · 

  8 min read